SHEA PITTS: Open Payments
NPI 1720501430 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 111 payments from 23 companies in 2025. Trend: 2023 $1,061 · 2024 $1,262 · 2025 $1,707
Food & beverage: $1,707
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $249 |
| Otsuka America Pharmaceutical, Inc. | 10 | $161 |
| Novo Nordisk Inc | 10 | $159 |
| Lundbeck LLC | 7 | $153 |
| Dexcom, Inc. | 7 | $145 |
| Lilly USA, LLC | 9 | $143 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| Exact Sciences Corporation | 4 | $69 |
Products named: REXULTI, Dexcom G6 Transmitter, Wegovy, VRAYLAR, QULIPTA, JARDIANCE, HETLIOZ, XIFAXAN.
Industry payments across TN — which companies pay providers there.
